Hester Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 187.01 million against INR 117.75 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 59.58 million against INR 40.91 million a year ago. Profit from ordinary activities before tax was INR 51.47 million against INR 34.47 million a year ago. Net profit from ordinary activities after tax and net profit for the period was INR 27.65 million or INR 3.25 per basic and diluted share against net profit for the period of INR 26.31 million or INR 5.07 per basic and diluted share a year ago.

For the nine months, on standalone basis, the company reported net sales/income from operations of INR 480.81 million against INR 347.99 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 149.91 million against INR 127.19 million a year ago. Profit from ordinary activities before tax was INR 127.35 million against INR 106.37 million a year ago. Net profit from ordinary activities after tax and net profit for the period was INR 72.16 million or INR 8.48 per basic and diluted share against net profit for the period of INR 73.65 million or INR 14.19 per basic and diluted share a year ago.